Sara Rinala, MD
Obstetrics & Gynecology · Cincinnati, OHNPI 1861651176
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,065 of the $1,207 with a category attached, or 88.3%. It is spread thinly across 22 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations.
Across 61 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$213
- Mayne Pharma Commercial LLC$120
- Coopersurgical, Inc.$97
- AbbVie$94
- Aspira Women's Health Inc$88
- Gynesonics, Inc.$83
- plus $511 from 16 others
What the payments were for
- Food & beverage$1,06588%
- Education$12711%
- Gifts$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $213 |
| Mayne Pharma Commercial LLC | 7 | $120 |
| Coopersurgical, Inc. | 5 | $97 |
| AbbVie | 6 | $94 |
| Aspira Women's Health Inc | 1 | $88 |
| Gynesonics, Inc. | 4 | $83 |
| Pfizer | 3 | $68 |
| Sage Therapeutics, LLC | 3 | $63 |
| Merck | 3 | $52 |
| Exeltis, USA Inc. | 3 | $51 |
| Therapeuticsmd, Inc. | 3 | $47 |
| Bayer | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| AMAG Pharmaceuticals, Inc. | 2 | $28 |
| Avion Pharmaceuticals | 2 | $25 |
| Roche Diagnostics Corporation | 1 | $21 |
| Organon | 2 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
| Daiichi Sankyo Inc. | 1 | $11 |
How this compares
$1,207 in reported general payments places this provider in the 65th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $645 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $150 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cincinnati
- David SchwartzCincinnati$169K
- Gerard ReillyCincinnati$74K
- Michael KarramCincinnati$47K
- Sunbal JavaidCincinnati$32K
- James SosnowskiCincinnati$31K
- Gretchen FermannCincinnati$31K
- Rocco RossiCincinnati$18K
- Meredith PensakCincinnati$14K
- David DhanrajCincinnati$12K
- David SheynCincinnati$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.